Skip to content

Online Breathwork-Assisted Therapy for Social Anxiety

Online Breathwork-Assisted Therapy for Social Anxiety - Breathe hard to breathe easy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57397
Enrollment
96
Registered
2025-01-13
Start date
2025-07-16
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social anxiety Social phobia Social anxiety

Interventions

Following t0 assessment, participants will be assigned a therapist who will lead the preparation and integration sessions and a trained facilitator who will lead the breathwork sessions. Following t

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Fluent in the English or Dutch language Aged between 18 and 65 LSAS score =30 Written informed consent

Exclusion criteria

Exclusion criteria: Hypotension (diastolic < 60 mmHg; systolic > 90 mmHg) or hypertension  (diastolic > 90 mmHg; systolic > 140 mmHg) History or presence of psychotic or bipolar disorders or first-degree relatives  suffering from this Presence of current respiratory diseases, except medically managed asthma, allergic rhinitis, dust mite allergy. Presence of cardiovascular/heart diseases. History of recurrent fainting (2 or more in a year with unknown aetiology) or syncope, epilepsy or seizures History of diagnosed panic disorder or panic attacks,  Having had adverse reactions with prior breathwork sessions (i.e., fainting),  Pregnancy, thinking one might be pregnant, trying to get pregnant, or  breastfeeding Any problems affecting the ability to pace breathing (i.e., active/chronic  respiratory infection including blocked nose/cough/cold/fever, etc.),  breathlessness, abnormally slow breathing (bradypnea), or abnormally fast  breathing (tachypnoea), any other physical/mental health conditions or current  life events impairing the ability to engage in activities involving breath  control Taking any regular medication other than the contraceptive pill, including  medications to reduce blood pressure (i.e., Ramipril or other ACE-inhibitors)  and beta-blockers (i.e., Propranolol).

Design outcomes

Primary

MeasureTime frame
Social anxiety - Liebowitz Social Anxiety Scale (LSAS)

Secondary

MeasureTime frame
Rater-assessed performance in the Getting Acquainted Task (GAT) Heart rate variability (HRV) Salivary Cortisol (SC) Therapeutic alliance - Working Alliance Inventory - Self-Report (WAI-SR) Treatment expectancy - Credibility and Expectancy Questionnaire (CEQ) Openness to experience - Big Five Inventory (BFI) Suggestibility - Modified Tellegen Absorption Scale (MODTAS) ASC phenomenology - 5 Dimensions of Altered States of Consciousness (5D-ASC); Peak Experience Scale (PES) Empathy - Multifaceted Empathy Test (MET); Interpersonal Reactivity Index (IRI) Well-being - World Health Organisation Well-Being Index (WHO-5); Resilience - Resilience Scale (RS) Cognitive Flexibility - Cognitive Flexibility Index (CFI) Person perception - Implicit Association Task (IAT) Mood - Positive And Negative Affect Schedule (PANAS) Sleep - Groeningen Sleep Quality Scale (GSQS) Anxiety - State and Trait Anxiety InventoryEmotion dysregulation – Difficulties in Emotion Regulation Scale (DERS) Sexual communication - Dyadic Sexual Communication Scale (DSC) Female sexual functioning - Female Sexual Functioning Index (FSFI) Male sexual functioning - International Index of Erectile Function Couple empathy - Interpersonal Reactivity Index for Couples (IRI-C) Empathy - Inclusion of Other in Self scale (IOS) Partner responsiveness - Perceived Partner Responsiveness Scale (PPRS) Sexual pleasure - Sexual Pleasure Scale (SPS) Interoceptive awareness - Multidimensional Assessment of Interoceptive Awareness – 2 (MAIA-2) Qualitative description of participants’ subjective experience during BAT and role of therapy components Therapists’ qualitative description of the role of therapy components.  

Countries

Netherlands

Contacts

Public ContactM Cavarra

Universiteit Maastricht

fpn-pim_p154@maastrichtuniversity.nl?+31 433 88 22 10?

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026